PS
Priyanka Sunny Shah
About Priyanka Sunny Shah
Data last updated:
Priyanka Sunny Shah is a Director at Vitarag Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Vitarag Pharmaceuticals Private Limited reported revenue of ₹5,066 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vitarag Pharmaceuticals Private Limited U21001GJ2023PTC147006 | Director | 18 Dec 2023 | 2023 | ₹5,066 (FY 2025) | Active |
Board colleagues of Priyanka Sunny Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hardik Ajaykumar Mehta | 10430859 | Vitarag Pharmaceuticals Private Limited | Director |
| Riddhiben Devangbhai Sheth | 10430861 | Vitarag Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Priyanka Sunny Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priyanka Sunny Shah
Priyanka Sunny Shah currently holds 1 directorship: Vitarag Pharmaceuticals Private Limited (Director, since 18 Dec 2023, revenue ₹5,066 (FY 2025)).
Priyanka Sunny Shah was first appointed on 18 Dec 2023 as Director at Vitarag Pharmaceuticals Private Limited.
The current boards of Priyanka Sunny Shah's companies include Hardik Ajaykumar Mehta (Vitarag Pharmaceuticals Private Limited), Riddhiben Devangbhai Sheth (Vitarag Pharmaceuticals Private Limited).